CorVel (CRVL) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
15 Jul, 2026Strategic vision and approach
Focus on timely risk management, leveraging decades of experience and innovation that blends technology with human expertise.
Dedicated to providing consistent, empathetic support to improve outcomes and recovery.
Service offerings and technology
Delivers advanced care management using AI, machine learning, and NLP to reduce healthcare costs and enhance claims processes.
Offers a broad suite of services: workers' comp, liability, case management, pharmacy benefits, virtual care, and payment integrity.
Proprietary Care MC platform provides real-time updates, predictive analytics, and customizable tools for all stakeholders.
Financial performance and market position
Achieved over $959 million in annual revenue, managing 393,000 claims and reviewing $44B in medical charges annually.
Maintains a 23.5% average ROE, 7.3% revenue CAGR, no long-term debt, and strong free cash flow.
Ranked 5th largest third-party administrator by 2025 gross revenue, with $941 million and 8% YoY growth.
Latest events from CorVel
- Shareholders to vote on board elections, auditor ratification, and executive pay amid leadership transition.CRVL
Proxy filing26 Jun 2026 - Key votes include director elections, auditor ratification, and executive pay approval.CRVL
Proxy filing26 Jun 2026 - Revenue, EPS, and net income rose, driven by Network Solutions, CERIS, and tech investments.CRVL
Q4 202620 May 2026 - Revenue and EPS rose, with AI-driven efficiency and strong cash supporting growth.CRVL
Q3 20265 Feb 2026 - Technology-driven care management and financial strength position the firm as a top industry innovator.CRVL
Investor presentation3 Feb 2026 - Revenue up 11.3% and EPS up 10% as AI and new accounts drive growth and efficiency.CRVL
Q1 20252 Feb 2026 - Revenue up 13% and EPS up 39% year-over-year, with strong cash and AI-driven efficiency.CRVL
Q3 20259 Jan 2026 - Director elections, auditor ratification, and a new stock plan headline a governance-focused agenda.CRVL
Proxy Filing1 Dec 2025 - Six directors and the external auditor are up for shareholder vote at the August 2024 meeting.CRVL
Proxy Filing1 Dec 2025